Human CYP2C19 Gene Typing Detection Reagent Kit (PCR-Fluorescent Probe Method)

PCR-based detection kit for HCMV nucleic acids used in early diagnosis and assessment of fetal, neonatal, and maternal infections. Enables timely clinical management of HCMV-related complications.

A diagnostic test kit for the detection of hepatitis C virus nucleic acid using fluorescent PCR methodology. This kit is designed for laboratory use in identifying HCV infection through nucleic acid amplification.

A quantitative diagnostic test kit for detecting human cytomegalovirus nucleic acid using fluorescence PCR technology. This kit enables both detection and quantification of CMV genetic material for clinical diagnostic purposes.

PCR-based fluorescence hybridization kit for genetic deafness gene detection and screening. Identifies hereditary hearing loss mutations through real-time PCR flow cytometry analysis, enabling early diagnosis and genetic counseling in clinical and research laboratories.

Molecular diagnostic kit for detecting Chlamydia trachomatis nucleic acids using PCR fluorescent probe methodology. Provides rapid, specific, and sensitive detection for early diagnosis of asymptomatic or mild infections.

Molecular diagnostic kit for detecting Neisseria gonorrhoeae nucleic acids using PCR technology. Supports epidemiological surveillance and monitoring of sexually transmitted diseases.

SARS-CoV-2 Nucleic Acid Detection Kit using fluorescent PCR method for rapid and accurate identification of COVID-19 infection. The kit enables qualitative detection of viral RNA in respiratory specimens, supporting clinical diagnosis and epidemiological surveillance. Designed for laboratory use with high sensitivity and specificity.

A diagnostic kit for genotyping of the human CYP2C19 gene.

A diagnostic kit for detecting CYP2C19 gene polymorphisms in human samples to guide personalized medication therapy.

A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.

Specialized gene detection kit for analyzing CYP2D6 genetic variations to predict drug metabolism and response. This test enables precision medicine by guiding drug selection and dosing for individual patients.

CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.